ESC 365 - What was it approved for in Europe

Back

HFA Premium Access

What was it approved for in Europe – The EMA recommendations.

Session: What a busy clinician needs to know about LCZ696 for heart failure

Topic: Miscellaneous

Speaker: Doctor K. Prasad (London, GB)

Event: HEART FAILURE 2016

Congress Presentation

About the speaker

Doctor Krishna Prasad

Medicines and Healthcare Products Regulatory Agency, London (United Kingdom of Great Britain & Northern Ireland)

1 presentation

0 follower

6 more presentations in this session

The drug and the PARADIGM-HF trial.

Speaker: Professor J. McMurray (Glasgow, GB)

Access

Slides

Video

What the 2016 guidelines say.

Speaker: Professor P. Ponikowski (Wroclaw, PL)

Access

Slides

Video

LCZ696 and the use of biomarkers.

Speaker: Professor S. Solomon (Boston, US)

Access

Slides

Video

LCZ696 and Alzheimers?

Speaker: Professor A. Zeiher (Frankfurt, DE)

Access

Slides

Video

LCZ696 and drug-drug interactions?

Speaker: Professor G. Rosano (London, GB)

Access

Access the full session

What a busy clinician needs to know about LCZ696 for heart failure

Speakers: Doctor K. Prasad, Professor J. McMurray, Professor P. Ponikowski, Professor S. Solomon, Professor A. Zeiher...

Access

About the event

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

Congress

What was it approved for in Europe – The EMA recommendations.

About the speaker

Doctor Krishna Prasad

6 more presentations in this session

The drug and the PARADIGM-HF trial.

What the 2016 guidelines say.

LCZ696 and the use of biomarkers.

LCZ696 and Alzheimers?

LCZ696 and drug-drug interactions?

Access the full session

What a busy clinician needs to know about LCZ696 for heart failure

About the event

HEART FAILURE 2016

ESC 365 is supported by